Given the results, the investigation of intranasal carbetocin in PWS has been halted. Intranasal carbetocin did not demonstrate clinical benefit for hyperphagia in patients with Prader-Willi syndrome ...

Shared pathogenic mechanisms between primary biliary cholangitis (PBC) and primary Sjogren syndrome could allow the development of treatment strategies that may benefit patients with both conditions.

The levels of NT-proBNP, left ventricular mass index, maximal wall thickness, and E/E′ ratio were higher in patients with worse neurological stages compared to those in the early neurological stages ...

Rituximab was linked to nearly triple the risk of hypogammaglobulinemia in the discovery cohort and a nearly 5-fold higher risk in the larger validation cohort. Patients with multiple sclerosis (MS) ...

Suggestions for improving the questionnaire included simplifying the language and adding visuals, but overall, the tool was well understood and accepted. A new study has found the Hemophilia Device ...

Subgroup analyses showed this PFS advantage was consistent across patient subgroups and alpha‐fetoprotein levels. For patients with advanced hepatocellular carcinoma (HCC) and a high CRAFITY score, ...

After switching to sirolimus or azathioprine the patients showed no evidence of active CIDP, even though they did not receive any other treatment. The use of tacrolimus to avoid rejection following ...

Rare Disease Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient ...